American Society of Hematology, Blood, 1(126), p. 6-7, 2015
DOI: 10.1182/blood-2015-05-643395
Full text: Download
In this issue of Blood, Ivanciu and Camire describe engineered factor (F)Xa variants with a spectrum of properties that broaden the utility of FXa as a treatment for bleeding.1.